Knight Therapeutics | GUD - Interest Income

Stock Price
7.53
Daily Change
-0.01 -0.13%
Monthly
3.15%
Yearly
27.20%
Q2 Forecast
7.39

Knight Therapeutics reported CAD2.46M in Interest Income for its fiscal quarter ending in September of 2024.





Interest Income Change Date
Acasti Pharma USD -0.36 172K Dec/2024
Aurora Cannabis CAD 1.85M 120K Sep/2025
Cronos Group USD 11.74M 2.74M Sep/2025
Dianthus Therapeutics USD 3.66M 255K Sep/2025
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
IQVIA Holdings USD 11M 2M Dec/2025
Knight Therapeutics CAD 2.46M 498K Sep/2024
Moderna USD 73M 8M Sep/2025
Revvity USD 0.4 8.34M Sep/2025
Tectonic Therapeutic USD 1.74M 217K Dec/2024
Tilray USD 12.83M 20.19M May/2024
Xeris Pharmaceuticals USD 1.16M 210K Sep/2025